Logo image of NVX

NOVONIX LTD-ADR (NVX) Stock Fundamental Analysis

NASDAQ:NVX - Nasdaq - US67010L1008 - ADR - Currency: USD

1.19  +0.01 (+0.85%)

Fundamental Rating

2

NVX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. NVX may be in some trouble as it scores bad on both profitability and health. NVX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NVX had negative earnings in the past year.
In the past 5 years NVX always reported negative net income.
In the past 5 years NVX always reported negative operating cash flow.
NVX Yearly Net Income VS EBIT VS OCF VS FCFNVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -33.09%, NVX is doing worse than 78.23% of the companies in the same industry.
NVX's Return On Equity of -54.38% is on the low side compared to the rest of the industry. NVX is outperformed by 79.03% of its industry peers.
Industry RankSector Rank
ROA -33.09%
ROE -54.38%
ROIC N/A
ROA(3y)-22.59%
ROA(5y)-20.43%
ROE(3y)-33.39%
ROE(5y)-27.76%
ROIC(3y)N/A
ROIC(5y)N/A
NVX Yearly ROA, ROE, ROICNVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NVX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NVX Yearly Profit, Operating, Gross MarginsNVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, NVX has more shares outstanding
The number of shares outstanding for NVX has been increased compared to 5 years ago.
The debt/assets ratio for NVX is higher compared to a year ago.
NVX Yearly Shares OutstandingNVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVX Yearly Total Debt VS Total AssetsNVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

NVX has an Altman-Z score of -0.75. This is a bad value and indicates that NVX is not financially healthy and even has some risk of bankruptcy.
NVX has a Altman-Z score of -0.75. This is in the lower half of the industry: NVX underperforms 79.84% of its industry peers.
NVX has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
NVX's Debt to Equity ratio of 0.29 is in line compared to the rest of the industry. NVX outperforms 40.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z -0.75
ROIC/WACCN/A
WACCN/A
NVX Yearly LT Debt VS Equity VS FCFNVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

NVX has a Current Ratio of 1.24. This is a normal value and indicates that NVX is financially healthy and should not expect problems in meeting its short term obligations.
NVX has a worse Current ratio (1.24) than 86.29% of its industry peers.
A Quick Ratio of 1.21 indicates that NVX should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.21, NVX is not doing good in the industry: 70.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.21
NVX Yearly Current Assets VS Current LiabilitesNVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for NVX have decreased strongly by -58.06% in the last year.
The Revenue for NVX has decreased by -15.76% in the past year. This is quite bad
Measured over the past years, NVX shows a very strong growth in Revenue. The Revenue has been growing by 20.91% on average per year.
EPS 1Y (TTM)-58.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-145.43%
Revenue 1Y (TTM)-15.76%
Revenue growth 3Y13.64%
Revenue growth 5Y20.91%
Sales Q2Q%-24.68%

3.2 Future

The Earnings Per Share is expected to decrease by -33.09% on average over the next years. This is quite bad
The Revenue is expected to grow by 66.08% on average over the next years. This is a very strong growth
EPS Next Y-9.09%
EPS Next 2Y4.45%
EPS Next 3Y-72.6%
EPS Next 5Y-33.09%
Revenue Next Year-36.01%
Revenue Next 2Y297.29%
Revenue Next 3Y52.37%
Revenue Next 5Y66.08%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVX Yearly Revenue VS EstimatesNVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
NVX Yearly EPS VS EstimatesNVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NVX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVX Price Earnings VS Forward Price EarningsNVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVX Per share dataNVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A cheap valuation may be justified as NVX's earnings are expected to decrease with -72.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.45%
EPS Next 3Y-72.6%

More info and screens

0

5. Dividend

5.1 Amount

NVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOVONIX LTD-ADR

NASDAQ:NVX (4/25/2025, 8:00:01 PM)

1.19

+0.01 (+0.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)08-20 2025-08-20
Inst Owners6.36%
Inst Owner Change0%
Ins Owners3.07%
Ins Owner ChangeN/A
Market Cap189.22M
Analysts84
Price Target1.44 (21.01%)
Short Float %0.31%
Short Ratio3.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.77%
PT rev (3m)-20.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.26%
EPS NY rev (3m)30.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-80.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.89
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.04
BVpS0.87
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.09%
ROE -54.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.59%
ROA(5y)-20.43%
ROE(3y)-33.39%
ROE(5y)-27.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.21
Altman-Z -0.75
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-145.43%
EPS Next Y-9.09%
EPS Next 2Y4.45%
EPS Next 3Y-72.6%
EPS Next 5Y-33.09%
Revenue 1Y (TTM)-15.76%
Revenue growth 3Y13.64%
Revenue growth 5Y20.91%
Sales Q2Q%-24.68%
Revenue Next Year-36.01%
Revenue Next 2Y297.29%
Revenue Next 3Y52.37%
Revenue Next 5Y66.08%
EBIT growth 1Y-6.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.45%
EBIT Next 3Y14.1%
EBIT Next 5Y13.32%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A